Clinical Trials
6 trialsNCT04503694 2026-05-22
REGINA
Jules Bordet Institute
Phase 2 Active not recruiting
NCT05392608 2026-05-22
SEQUEL-Breast
Borstkanker Onderzoek Groep
Phase 2 Active not recruiting
NCT04802590 2026-05-20
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
The Lymphoma Academic Research Organisation
Phase 2 Active not recruiting
NCT06275919 2026-05-13
MIRAGE
Istituto Oncologico Veneto IRCCS
Phase 2 Recruiting
NCT04055493 2026-05-11
ADAPTcycle
West German Study Group
Phase 3 Active not recruiting
NCT05907057 2026-05-08
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Servier
Phase 3 Recruiting